Skip to content
Clinical Trials – home
BulgariaBack to Bulgaria

Clinical trials in Pernik

39 clinical trials in Pernik, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.

Pernik at a glance
39
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

39 trials in Pernik

Open in trial search

Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.

A study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Loratadine
  • Sponsor:Pfizer Inc.

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Bronchiectasis

Recruiting

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Investigational
Countries:BulgariaBulgaria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:BI 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Cardiac failure

Recruiting

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Study on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drugNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB

Long‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis

InvestigationalNo placebo
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Fesoterodine
  • Sponsor:Maplight Therapeutics Inc.

A Study of fesoterodine and 5-[(1R,5R)-3-Azabicyclo[3.

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Fesoterodine
  • Sponsor:Maplight Therapeutics Inc.

Other cities in Bulgaria

The busiest research cities in the country

All 53 cities in Bulgaria

Clinical research in Pernik

What the registry says about research in the country

01 Respiratory Medicine

Innovative clinical research focusing on respiratory conditions, including studies of new treatments for severe asthma and COPD. Multiple trials are evaluating medications like verekitug and astegolimab to reduce disease exacerbations and improve patient outcomes.

  • Severe Asthma Management
  • COPD Treatment Advances
  • Respiratory Viral Infections

Several studies are exploring novel therapeutic approaches for patients with inadequate response to standard treatments.

02 Cardiovascular Research

Comprehensive studies targeting cardiovascular diseases, from acute myocardial infarction to stroke prevention. Trials are investigating innovative treatments like selatogrel for acute cardiac events and new approaches for atherosclerotic cardiovascular disease management.

  • Heart Attack Prevention
  • Stroke Risk Reduction
  • Atrial Fibrillation Treatment

Research focuses on both preventive measures and acute treatment strategies.

03 Chronic Disease Management

Groundbreaking research in chronic kidney disease and related conditions. Studies evaluate combination therapies and novel approaches for managing complex medical conditions including hypertension and urticaria.

  • Kidney Disease Therapy
  • Hypertension Management
  • Chronic Urticaria Treatment

Trials aim to improve long-term outcomes and quality of life for patients with chronic conditions.

04 Neurological Studies

Advanced research targeting Alzheimer's disease and associated symptoms. Clinical trials are evaluating new treatments for managing behavioral symptoms in dementia patients.

  • Dementia Management
  • Agitation Treatment
  • Behavioral Interventions

Focus on improving quality of life for patients and caregivers through innovative therapeutic approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.